Comparative Effectiveness and Safety of Upadacitinib Versus Risankizumab for Ulcerative Colitis. Dalal RS, Kwaning KM, Silvestri ME, Carlin AD, et al. Clin Gastroenterol Hepatol 2026 Feb 3:S1542-3565(26)00061.

Read + Share

Amedeo Smart

Independent Medical Education

Dalal RS, Kwaning KM, Silvestri ME, Carlin AD, et al. Comparative Effectiveness and Safety of Upadacitinib Versus Risankizumab for Ulcerative Colitis. Clin Gastroenterol Hepatol 2026 Feb 3:S1542-3565(26)00061.
PMID: 41643800